Serum specimens should be tested by an antiZika IgM assay Test appropriate specimen by Zika RNA PCRNAT Dengue Chikungunya Specimen positive for RNA patient POSITIVE for dengue ID: 532412
Download Presentation The PPT/PDF document "Serological Testing" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Serological Testing
Serum specimens should be tested by an IgM assay**
Test appropriate specimen by Zika
RNA
PCR/NAT
Dengue
Chikungunya
Specimen positive for RNA patient POSITIVE for dengue virus
Specimen negative for dengue virus RNA
Specimen positive for chikungunya virus – patient POSITIVE for chikungunya virus
Specimen negative for chikungunya virus RNA
Any Specimen positive for Zika virus RNA is POSITIVE for Zika virus
Specimen negative for Zika virus RNA
Zika, dengue & chikungunya IgM ELISA interpreted as presumptive positive, equivocal, or indeterminate. Proceed to PRNT
PRNTFinal interpretation is made bythe lab conducting the PRNT
2017 Zika Response: Algorithm for US Testing of SYMPTOMATIC NON-PREGNANT IndividualsSpecimens collected <14 days Following Symptom Onset
Results should be considered in the context of symptoms, exposure risk, and time point of specimen collection. **Antibody cross-reactivity to other flaviviruses complicates interpretation of the current anti-Zika IgM tests. Dengue IgM testing should be conducted for individuals with a potential dengue exposure and when a presumptive other flavivirus result is obtained.When testing urine and amniotic fluid with the CDC Trioplex assay, only report the Zika result.PRNT confirmation is not routinely recommended for Puerto Rico. Revised 8/9/17.
All tests
NEGATIVE
Reported as
No evidence of recent infection
Fig. 1Slide2
Dengue**
Chikungunya
Specimen positive, equivocal or presumptive dengue infection –
Forward for confirmation by
PRNT
Specimen negative for dengue IgM:
Patient
NEGATIVE for dengue infection
Specimen positive or presumptive chikungunya infection –Forward for confirmation by PRNT
Specimen negative for chikungunya IgM:Patient NEGATIVE for chikungunya infection
Specimen negative for
Zika IgM: Patient NEGATIVE for Zika infection
PRNTFinal interpretation is made by
the lab conducting the PRNT2017 Zika Response: Algorithm for US Testing of
SYMPTOMATIC NON-PREGNANT IndividualsSpecimens Collected <12 weeks Following Symptom Onset
Results should be considered in the context of symptoms, exposure risk, and time point of specimen collection.** Note antibody cross-reactivity to other flaviviruses complicates interpretation of the current anti-Zika IgM tests. Dengue IgM testing should be conducted for individuals with a potential dengue exposure and when a presumptive other flavivirus result is obtained.
PRNT confirmation is not routinely recommended for Puerto Rico. Revised 8/9/17.
**
Zika
IgM ELISA interpreted as presumptive positive, equivocal, or indeterminate.
Serological Testing
Serum specimens should be tested by an anti-Zika IgM assay
Test available and appropriate specimens by RNA NAT for ZIKV only
Any specimen Zika RNA positive: patient
POSITIVE
for Zika virus infection
Zika RNA not detected in any specimens.
Forward specimens for confirmation of Zika IgM by PRNT
Fig. 2Slide3
NOTE
:
For asymptomatic pregnant women with possible ongoing exposure through travel or unprotected sex, PCR NAT testing should be run three times during pregnancy, unless PCR or PRNT results are positive at any time before or during pregnancy.
NOTE: Pregnant women with possible exposure to Zika virus and who have a fetus with prenatal ultrasound findings consistent with congenital Zika virus infection should be tested. NAT and IgM testing should be performed on maternal serum and urine following the algorithm for symptomatic pregnant women. If amniocentesis is being performed as part of clinical care, NAT testing of amniocentesis specimens should also be performed. Testing of placental and fetal tissues may also be considered
. See this link for additional information for assessing epidemiologic risk:
http://www.cdc.gov/zika/geo/index.html
Revised 8/9/17.
2017 Zika Response: Algorithm for Testing of
SYMPTOMATIC PREGNANT Women Meeting Epidemiologic Criteria
If testing for asymptomatic pregnant women (with recent but no ongoing exposure) is requested, algorithm for symptomatic pregnant women will be followed Specimens collected <12 weeks
after return from travel or exposure
Test urine and serum by Zika RNA NAT and serum by Zika, dengue and chikungunya IgM serology.(Serum PCR for dengue and chikungunya will be performed on serum collected <14 days)
PCR is negative on both sample sources and IgM ELISA is indeterminate,
equivocal, or presumptive positiveby IgM serology.Forward serum for confirmation by PRNT
Fig. 3
Suggests acute infection: Repeat PCR on the original positive specimen source
Specimen repeats positive. Result as:
Virus
Detected
Zika
PCR is positive on 2 specimen sources, or PCR is positive on 1 specimen source and
Zika
IgM is positive
Specimen repeats negative: Result
as
: Virus Not Detected
and repeat IgM on a second serum collected in 2 weeks. Add comment: Discordant PCR results obtained; please submit a second serum specimen collected in 2 weeks for IgM serology to determine final interpretation.
If second specimen is IgM negative: Interpret as:
No Evidence of
Zika Virus Infection
Result as:
Virus Detected
Zika
virus PRNT >10 and dengue virus PRNT >10.
Flavivirus Infection: Specific Virus and Timing of infection cannot be determined.
For pregnant women without Zika virus exposure before the current pregnancy, positive IgM represents recent unspecified
flavivirus infectionZika, dengue & chikungunya virus PRNT <10. No evidence of
viral infection
Zika
PCR
is positive on one
specimen
source, but negative on the other and serum IgM
is negative
All specimens
negative (PCR dengue and chikungunya DOC
<
14 days of exposure):
Patient
negative for
all viruses
Recommend collection of
a convalescent serum
for additional
Zika
testing if second specimen will be collected
within 12 weeks
of exposure
for
Zika
IgM
If second specimen is IgM positive, interpret as:
Evidence of Acute
Zika
Infection
PCR is positive for chikungunya or dengue on serum (Serum DOC is
<
14 days of exposure), result as:
Virus Detected
Zika
, dengue or CHIK
virus PRNT
>
10, other viruses PRNT <10.
Z
ika
, Dengue, or Chikungunya Virus
Infection: Timing of infection cannot be determined.
For pregnant women without
Zika
, dengue or CHIK virus
exposure before the current pregnancy,
positive IgM represents
recent virus
infection